Literature DB >> 19763629

Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure.

Eva Kis1, Orsolya Cseprekál, Edina Bíró, Kata Kelen, Dóra Ferenczi, Andrea Kerti, Attila J Szabó, Antal Szabó, György S Reusz.   

Abstract

Arterial stiffness (Ast) individually predicts cardiovascular (CV) mortality. Ast increases via vascular calcification and can be characterized by pulse wave velocity (PWV). We assessed the influence of mineral and bone metabolism on Ast in dialyzed (D) and renal transplanted (Tx) children by measuring fetuin-A and bone markers [bone-specific alkaline phosphatase (BALP); beta-CrossLaps (beta)]. Normalized PWV/height (PWV/h) of 11 D and 17 Tx patients was measured by applanation tonometry. Levels of calcium (Ca), phosphate (P), fetuin-A, and bone markers were analyzed. Ca x P/fetuin-A ratio was calculated to characterize the balance of calcification and inhibition. Cumulative dose of calcitriol was also assessed. Fetuin-A was lower in D and Tx compared with healthy controls. Bone markers and Ca x P/ fetuin-A of D were significantly higher than those of Tx and controls. In D PWV/h correlated with Ca x P/fetuin-A and BALP (r=0.8; p=0.005, r=0.6, p=0.05, respectively); BALP correlated with Ca x P/fetuin-A (r=0.7, p=0.01). In Tx, there was a correlation between calcitriol administered before transplantation and PWV/h (r=0.5, p=0.04). Increased bone turnover was coupled with an increased potential of calcium-phosphate precipitation, as shown by the increased Ca x P/fetuin-A. It might explain the connection between disturbed mineral and bone metabolism and Ast. Tx might be beneficial on Ast, though follow-up studies are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763629     DOI: 10.1007/s00467-009-1292-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

Review 1.  Arterial stiffness and function in end-stage renal disease.

Authors:  Gérard M London; Sylvain J Marchais; Alain P Guerin
Journal:  Adv Chronic Kidney Dis       Date:  2004-04       Impact factor: 3.620

Review 2.  Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse.

Authors:  Markus Ketteler; Vincent Brandenburg; Willi Jahnen-Dechent; Ralf Westenfeld; Jürgen Floege
Journal:  Nephrol Dial Transplant       Date:  2005-02-22       Impact factor: 5.992

3.  Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.

Authors:  Sandro Mazzaferro; Marzia Pasquali; Francesco Pugliese; Giusi Barresi; Iacopo Carbone; Marco Francone; Daniela Sardella; Franco Taggi
Journal:  Am J Nephrol       Date:  2007-01-26       Impact factor: 3.754

4.  Effect of haemodialysis on markers of bone turnover in children.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

5.  Bone metabolism and mineral density following renal transplantation.

Authors:  G S Reusz; A J Szabó; F Péter; E Kenesei; P Sallay; K Latta; A Szabó; A Szabó; T Tulassay
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

6.  The serum hormone levels, phosphate complex concentrations and enzyme activities in haemodialysed and kidney-transplanted children.

Authors:  A Szabó; P Sallay; I Tausz
Journal:  Acta Paediatr Hung       Date:  1990

Review 7.  Novel insights into vascular calcification.

Authors:  M Ketteler; C Giachelli
Journal:  Kidney Int Suppl       Date:  2006-12       Impact factor: 10.545

8.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

9.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.

Authors:  Alexander Heiss; Thomas Eckert; Anke Aretz; Walter Richtering; Wim van Dorp; Cora Schäfer; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

View more
  10 in total

Review 1.  The bone-vascular axis in chronic kidney disease.

Authors:  Linda Demer; Yin Tintut
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

2.  Aortic stiffness in ESRD children before and after renal transplantation.

Authors:  Bilal Aoun; Fleur Lorton; Hala Wannous; Bernard Lévy; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

3.  Intima media thickness in children undergoing dialysis.

Authors:  Luis Antonio Chavarria; Alejandra Aguilar-Kitsu; Patricia Rosas; Arturo Fajardo; Leticia Mendoza-Guevara; Lorena Sanchez; Claudia Zepeda; Pilar Ibarra; Alejandro Luna; Bengt Lindholm; Elvia García-López
Journal:  Pediatr Nephrol       Date:  2012-05-03       Impact factor: 3.714

Review 4.  Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

Authors:  Rukshana Shroff; Catherine Quinlan; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2010-11-16       Impact factor: 3.714

Review 5.  Cardiovascular risk assessment in children with chronic kidney disease.

Authors:  Rukshana Shroff; Arianna Dégi; Andrea Kerti; Eva Kis; Orsolya Cseprekál; Kálmán Tory; Attila J Szabó; George S Reusz
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

6.  Arterial Stiffness in Children: Pediatric Measurement and Considerations.

Authors:  Jonathan D Savant; Susan L Furth; Kevin E C Meyers
Journal:  Pulse (Basel)       Date:  2015-02-18

7.  Body composition and arterial stiffness in pediatric patients with chronic kidney disease.

Authors:  Vasiliki Karava; Nikoleta Printza; John Dotis; Despoina Demertzi; Christina Antza; Vasilios Kotsis; Fotios Papachristou; Stella Stabouli
Journal:  Pediatr Nephrol       Date:  2019-03-29       Impact factor: 3.714

Review 8.  Pathophysiology and consequences of arterial stiffness in children with chronic kidney disease.

Authors:  Karolis Azukaitis; Augustina Jankauskiene; Franz Schaefer; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2020-09-07       Impact factor: 3.714

9.  Fetuin-A and Ghrelin Levels in Children with End Stage Renal Disease and the Effect of a Single Hemodialysis Session on Them.

Authors:  Mohamed Gamal Shouman; Nagwa Abdallah Ismail; Ahmed Badr; Safaa Mohamed Abdelrahman; Shadia Ragab; Hebatallah Farouk
Journal:  Open Access Maced J Med Sci       Date:  2015-07-17

10.  Circulating calcification inhibitors are associated with arterial damage in pediatric patients with primary hypertension.

Authors:  Piotr Skrzypczyk; Anna Stelmaszczyk-Emmel; Michał Szyszka; Anna Ofiara; Małgorzata Pańczyk-Tomaszewska
Journal:  Pediatr Nephrol       Date:  2021-02-18       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.